SRC and cancer: In contrast to viral oncoproteins, Src alone is insufficient to transform cells in vitro, and activating mutations of SFK are rarely observed in cancer [27, 28], suggesting further control by specific Src regulators that promote or restrain its tumorigenic properties [29, 30].